SC 13G/A: Jaguar Health, Inc.

Ticker: JAGX · Form: SC 13G/A · Filed: Jun 10, 2024 · CIK: 1585608

Jaguar Health, INC. SC 13G/A Filing Summary
FieldDetail
CompanyJaguar Health, INC. (JAGX)
Form TypeSC 13G/A
Filed DateJun 10, 2024
Risk Levellow
Pages5
Reading Time6 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by Jaguar Health, Inc..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G/A filing submitted by Jaguar Health, INC. (ticker: JAGX) to the SEC on Jun 10, 2024.

What is the risk level of this SC 13G/A filing?

This filing has been assessed as low risk.

What are the key financial figures in this filing?

Key dollar amounts include: $0.0001 (Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o).

How long is this filing?

Jaguar Health, INC.'s SC 13G/A filing is 5 pages with approximately 1,488 words. Estimated reading time is 6 minutes.

Where can I view the full SC 13G/A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 1,488 words · 6 min read · ~5 pages · Grade level 8.1 · Accepted 2024-06-10 11:26:28

Key Financial Figures

Filing Documents

From the Filing

SC 13G/A 1 doc1.htm NONE Schedule 13G UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Jaguar Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 47010C805 (CUSIP Number) June 10, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 47010C805 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Iliad Research & Trading, L.P. 11-3688679 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Utah NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 393,700 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 393,700 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 393,700 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.12*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN FOOTNOTES * Based on the 6,431,830 shares outstanding on June 5, 2024 CUSIP No. 47010C805 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Iliad Management, LLC 20-0411071 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 393,700 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 393,700 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 393,700 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.12*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO FOOTNOTES * Based on the 6,431,830 shares outstanding on June 5, 2024 CUSIP No. 47010C805 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Fife Trading, Inc. 36-4151891 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 393,700 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 393,700 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 393,700 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.12*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO FOOTNOTES * Based on the 6,431,830 shares outstanding on June 5, 2024 CUSIP No. 47010C805 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) John M. Fife 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 393,700 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER 393,700 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 393,700 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.12*% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN FOOTNOTES * Based on the 6,431,830 shares outstanding on June 5, 2024 Item 1. (a) Name of Issuer Jaguar Health, Inc. (b) Address of Issuer's Principal Executive Offices 200 Pine Street, Suite 400 San Francisco, CA 94104 Item 2. (a) Name of Person Filing This report is filed by Iliad Research and Trading, LP, Iliad Management, LLC, Fife Trading, Inc., and John M. Fife with respect to the shares of Common Stock, $0.0001 par value per share, of the Issuer that are directly benef

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing